> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review BrainStorm ALS Submission
- URL: https://www.fdaweb.com/panel-to-review-brainstorm-als-submission/
- Published: 2023-07-26T12:00:00.000Z
- Updated: 2026-09-14T18:46:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154956

*Federal Register* notice: FDA is announcing a 9/27 Cellular, Tissue, and Gene Therapies Advisory Committee meeting. Panel members are scheduled to discuss and make recommendations on a BrainStorm Therapeutics supplemental BLA for debamestrocel (autologous bone marrow-derived mesenchymal stromal cells induced to secrete neurotrophic factors). The company’s submission is seeking an indication for treating amyotrophic lateral sclerosis. To view the notice, click [here](https://public-inspection.federalregister.gov/2023-15923.pdf?ref=fdaweb.com).